Show simple item record

dc.contributor.authorThorat, M
dc.contributor.authorCuzick, J
dc.contributor.authorJones, J
dc.contributor.authorLevey, P
dc.date.accessioned2021-08-02T16:47:15Z
dc.date.available2021-07-30
dc.date.available2021-08-02T16:47:15Z
dc.identifier.citationThorat, Mangesh A et al. “Prognostic and predictive value of HER2 expression in ductal carcinoma in situ: Results from the UK/ANZ DCIS randomized trial.” Clinical cancer research : an official journal of the American Association for Cancer Research, clincanres.1239.2021. 11 Aug. 2021, doi:10.1158/1078-0432.CCR-21-1239
dc.identifier.issn1078-0432
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/73378
dc.publisherAmerican Association for Cancer Researchen_US
dc.relation.ispartofClinical Cancer Research
dc.titlePrognostic and predictive value of HER2 expression in ductal carcinoma in situ: Results from the UK/ANZ DCIS randomized trial.en_US
dc.typeArticleen_US
dc.identifier.doi10.1158/1078-0432.CCR-21-1239
pubs.notesNot knownen_US
pubs.publication-statusAccepteden_US
pubs.publisher-urlhttps://doi.org/10.1158/1078-0432.CCR-21-1239
dcterms.dateAccepted2021-07-30
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
qmul.funderCancer Prevention::Cancer Research UKen_US
qmul.funderCancer Prevention::Cancer Research UKen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record